Bionano To Present Optical Genome Mapping Utility Across Cancer Research Applications At The CGC 2024 Annual Meeting
Portfolio Pulse from Benzinga Newsdesk
Bionano Genomics, Inc. (NASDAQ:BNGO) will present its optical genome mapping (OGM) technology at the Cancer Genomics Consortium (CGC) 2024 Annual Meeting. The presentation will include data from a multi-site study and several scientific posters illustrating OGM's utility in hematological malignancy cancer research.
August 01, 2024 | 12:09 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Bionano Genomics, Inc. (NASDAQ:BNGO) will present its optical genome mapping (OGM) technology at the CGC 2024 Annual Meeting, showcasing its utility in hematological malignancy cancer research through a multi-site study and several scientific posters.
The presentation of Bionano's OGM technology at a major conference, along with data from a multi-site study and several scientific posters, is likely to generate positive attention and interest in the company's products, potentially boosting its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100